Drug company Shire (LON:SHP) is in good health, Jefferies reckons. The stockbroker upped its target price on Shire shares this morning by 6% to 6150p and stuck with its ‘buy’ rating. It... [[ This...
[[ This is a content summary only. Visit my website for full links, other content, and more! ]]
http://ift.tt/1dzRkvw @MasterMetals MasterMetals Blog